Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_assertion type Assertion NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_head.
- NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_assertion description "[Thus CD44 may be a promising new epigenetic marker for diagnosis and a potential therapeutic target for the treatment of specific lymphoma subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_provenance.
- NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_assertion evidence source_evidence_literature NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_provenance.
- NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_assertion SIO_000772 20920234 NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_provenance.
- NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_assertion wasDerivedFrom befree-20150227 NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_provenance.
- NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_assertion wasGeneratedBy ECO_0000203 NP295840.RAK0TnzCAcMPHFg5HWg47bnpGMribwMgLGa0555MbqXOA130_provenance.